RAPT Therapeutics Slips 9% After Pricing Public Offering

On:

Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.

The company today priced its public offering of 4,054,055 shares at $18.50 per share.

Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.

RAPT has traded in the range of $9.85- $40.74 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Tether May Be Holding Over 55,000 $BTC in a Single Address, Researcher Finds
  2. Bitcoin Predicted To Soar Past $35,000 By Summer As Wallets Holding At Least 1 BTC Hits The 1 Million Mark
  3. Fidelity Exec's Analysis of BTC in Portfolio Diversification
  4. Patrick Shyu ('TechLead') Says a Spot Bitcoin ETF Approval in U.S. Will Make Him Rich
  5. $BTC: Anthony Pompliano Says ‘In Our Darkest Moment, Bitcoin Steps to the Forefront’